The team

The people behind SambaTrials

Clinical development and licensing advisory for Brazil and Latin America — grounded in medical, regulatory, and dealmaking experience.

Salvador Gullo, MD, PhD

Salvador Gullo

MD, PhD · Board Certified Medical Affairs Specialist

Partner

Brazilian physician and healthcare executive. Trained as a transplant surgeon at PUCRS in Porto Alegre, he led the kidney and pancreas transplant program at Hospital São Lucas — over 300 kidney and 78 pancreas transplants — before transitioning to healthcare management. He directed Unimed Porto Alegre's network serving 600,000 patients and authored Patient Safety: The True Healthcare Revolution. In 2019 he founded SAFETY4ME and moved to Carlsbad, California, where he completed a post-doctorate at SDSU. Board Certified as a Medical Affairs Specialist with deep expertise in patient safety, value-based care, and doctor relationships, he leads SambaTrials' clinical development practice — connecting biotech sponsors to Brazilian research centers and advising on site feasibility, ANVISA strategy, and medical-affairs operations. Fluent in Portuguese and English.

LinkedIn
Daniel Branco

Daniel Branco

MD, PhD, MBA

Partner

Brazilian physician and healthcare executive. Most recently Senior Director of Corporate Development & LatAm Medical Affairs at Artiva Biotherapeutics, where he led business development and IPO financial modeling and built the company's medical-affairs and clinical-operations presence across Brazil, Mexico, and Argentina. Earlier, he was Vice President of Oncology at Hospital Israelita Albert Einstein in São Paulo and Chief Medical Officer at Hospital Mãe de Deus in Porto Alegre. He is the founder of BioAlma, the AI intelligence platform that powers SambaTrials' landscape research, and leads SambaTrials' licensing advisory practice — drawing on over half a billion dollars in transactions across business and corporate development. Based in San Diego. Fluent in Portuguese and English.

LinkedIn